首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1236106

全球毛細胞白血病市場：規模、研究和預測，按治療（化療、靶向治療）、區域分析，2022-2029 年

Global Hairy Cell Leukemia Market Size study & Forecast, by Therapy (Chemotherapy and Targeted Therapy) and Regional Analysis, 2022-2029

出版日期: 2023年02月27日 | 出版商:

Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

毛細胞白血病是一種骨髓產生過多淋巴細胞的癌症。

它是血液和骨髓的惡性腫瘤。它保持穩定多年並引起感染。由於預測期內白血病患病率上升和診斷率提高等因素，毛細胞白血病市場正在擴大。

根據美國癌症協會 2022 年的數據，到 2022 年將診斷出約 60,650 例新的白血病（所有類型）病例，其中約有 20,160 例新的慢性淋巴細胞白血病 (CLL) 病例。根據同一份文件，CLL 還佔新診斷白血病的大約四分之一。此外，根據 2021 年 NORD 的數據，大約有 6,000 人患有毛細胞白血病，美國每年診斷出 600-800 例新病例。另一方面，市場參與者對癌症治療進展的支出增加以及研發活動的增加正在為市場創造有利可圖的機會。然而，缺乏意識和有限的醫療服務阻礙了整個 2022-2029 年預測期內的市場增長。

全球毛細胞白血病市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於老年人口不斷增長和慢性淋巴細胞白血病患病率上升，北美在收入方面佔據了市場主導地位。另一方面，由於研發費用增加和藥品成本增加等因素，預計北美在預測期內將以最高複合年增長率增長。

近期市場趨勢

2022 年 8 月，阿斯利康的 Calquence 片劑上市，用於治療慢性淋巴細胞白血病 (CLL)、小淋巴細胞白血病 (SLL) 和先前治療過的複發或難治性套細胞淋巴瘤 (MCL)，並獲得 FDA 批准。
2022 年 5 月，吉森大學開展了一項 2/3 期臨床試驗，評估毛細胞白血病患者皮下注射克拉屈濱一個週期的療效和副作用。

全球毛細胞白血病市場報告範圍

歷史數據：2019-2020-2021
估算基準年：2021 年
預測期：2022-2029
報告範圍：收入預測、公司排名、競爭格局、增長因素、趨勢
按地區劃分：北美、歐洲、亞太地區、拉丁美洲、世界其他地區
定制範圍：免費報告定制（最多 8 個工作小時）。按國家、地區和部門劃分的範圍的添加和更改。

本研究的目的是弄清近年來各個領域和國家的市場規模，並對未來幾年的市場規模進行預測。該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。此外，它還結合了利益相關者投資的潛在微觀市場機會，以及主要參與者的競爭格局等詳細分析。

內容

第 1 章執行摘要

市場概況
2019-2029 年各細分市場的全球市場估計和預測
- 2019-2029 年按地區劃分的軟細胞白血病市場
- 2019-2029 年按治療分類的軟細胞白血病市場
主要趨勢
調查方法
調查先決條件

第 2 章全球毛細胞白血病市場定義和範圍

調查目的
市場定義和範圍
- 調查範圍
- 工業發展
本次調查涵蓋的年份
貨幣兌換率

第 3 章毛細胞白血病的全球市場動態

毛細胞白血病市場影響分析 (2019-2029)
- 市場驅動力
  - 白血病患病率上升
  - 不斷增長的診斷率
- 市場挑戰
  - 缺乏認識且醫療服務有限
- 市場機會
  - 增加用於推進癌症治療的支出
  - 激活市場參與者的研發活動

第 4 章全球毛細胞白血病市場行業分析

波特 5 力模型
- 供應商的議價能力
- 買家的議價能力
- 新進入者的威脅
- 替代品的威脅
- 競爭公司之間的敵對關係
波特 5 力模型的未來方法 (2019-2029)
害蟲分析
- 政治
- 經濟的
- 社交
- 技術
最佳投資機會
關鍵成功策略
業內人士的前景
分析師的建議和結論

第 5 章風險評估 COVID-19 影響

評估 COVID-19 對行業的總體影響
COVID-19 之前和 COVID-19 之後的市場情景

第 6 章。全球毛細胞白血病市場：按治療分類

市場概況
全球毛細胞白血病市場：按療法、按性能 - 潛力分析
2019-2029 年全球毛細胞白血病市場按治療方法估算和預測
毛細胞白血病市場細分分析
- 化療
- 靶向治療

第 7 章。全球毛細胞白血病市場：區域分析

細胞白血病市場，按地區劃分的市場概況
北美
- 美國
  - 按療法估算和預測，2019-2029 年
- 加拿大
歐洲毛細胞白血病市場概況
- 英國
- 德國
- 法國
- 西班牙
- 意大利
- 其他歐洲
亞太地區毛細胞白血病市場概況
- 中國
- 印度
- 日本
- 澳大利亞
- 韓國
- 其他亞太地區
拉丁美洲毛細胞白血病市場概況
- 巴西
- 墨西哥
- 其他拉丁美洲地區
世界其他地區

第 8 章衝突信息

頂級市場策略
公司簡介
- 安進公司
  - 關鍵信息
  - 概覽
  - 財務（僅當數據可用時）
  - 產品概述
  - 近期趨勢
- AstraZeneca PLC
- Gilead Sciences
- F. Hoffmann-La Roche Ltd
- Astellas Pharma
- Johnson & Johnson
- Merck KGaA
- Biogenomics Limited
- AbbVie Inc.
- Pfizer Inc.

第九章研究過程

研究過程
- 數據挖掘
- 分析
- 市場評估
- 驗證
- 出版
調查的特點
調查先決條件

簡介目錄圖表

The global Hairy Cell Leukemia Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Hairy Cell Leukemia is a type of cancer in which the bone marrow produces an excessive number of lymphocytes. It is a blood and bone marrow malignancy. It remains stable for years and creates infections. The Hairy Cell Leukemia market is expanding because of factors such as the rising prevalence of leukemia and growing diagnosis rate in the forecast period.

According to the American Cancer Society's 2022 data, nearly 60,650 new cases of leukemia (all types) are expected to be diagnosed in 2022, with chronic lymphocytic leukemia (CLL) accounting for approximately 20,160 new cases. Furthermore, according to the same source, CLL accounts for roughly one-quarter of newly diagnosed cases of leukemia. Furthermore, according to NORD data for 2021, approximately 6,000 people are affected by hairy cell leukemia, with 600-800 new cases diagnosed in the United States each year. Whereas rising spending towards the advancement of cancer treatment and growing R&D activities by market players create lucrative opportunities for the market. However, a lack of awareness and limited health services hamper the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Hairy Cell Leukemia Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing geriatric population, and growing prevalence of chronic lymphocytic leukemia. Whereas North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing demand spending on research and development and growing pharmaceutical spendings.

Major market players included in this report are:

Amgen Inc.
AstraZeneca PLC
Gilead Sciences
F. Hoffmann-La Roche Ltd
Astellas Pharma
Johnson & Johnson
Merck KGaA
Biogenomics Limited
AbbVie Inc.
Pfizer Inc.

Recent Developments in the Market:

In August 2022, AstraZeneca's Calquence tablet was approved by the FDA for the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic leukemia (SLL), and previously treated relapsed or refractory mantle cell lymphoma (MCL).
In May 2022, The University of Giessen conducted a Phase II/III clinical study to evaluate the efficacy and side effects of one cycle of subcutaneous cladribine treatment in patients with hairy cell leukemia.

Global Hairy Cell Leukemia Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Therapy, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

Chemotherapy
Targeted Therapy

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Hairy Cell Leukemia Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Hairy Cell Leukemia Market, by Therapy, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Hairy Cell Leukemia Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Hairy Cell Leukemia Market Dynamics

3.1. Hairy Cell Leukemia Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising prevalence of leukemia
  - 3.1.1.2. Growing diagnosis rate
- 3.1.2. Market Challenges
  - 3.1.2.1. Lack of awareness and limited health services
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising spending towards advancement of cancer treatment
  - 3.1.3.2. Growing R&D activities by market players

Chapter 4. Global Hairy Cell Leukemia Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Hairy Cell Leukemia Market, by Therapy

6.1. Market Snapshot
6.2. Global Hairy Cell Leukemia Market by Therapy, Performance - Potential Analysis
6.3. Global Hairy Cell Leukemia Market Estimates & Forecasts by Therapy 2019-2029 (USD Billion)
6.4. Hairy Cell Leukemia Market, Sub-Segment Analysis
- 6.4.1. Chemotherapy
- 6.4.2. Targeted Therapy

Chapter 7. Global Hairy Cell Leukemia Market, Regional Analysis

7.1. Hairy Cell Leukemia Market, Regional Market Snapshot
7.2. North America Hairy Cell Leukemia Market
- 7.2.1. U.S. Hairy Cell Leukemia Market
  - 7.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
- 7.2.2. Canada Hairy Cell Leukemia Market
7.3. Europe Hairy Cell Leukemia Market Snapshot
- 7.3.1. U.K. Hairy Cell Leukemia Market
- 7.3.2. Germany Hairy Cell Leukemia Market
- 7.3.3. France Hairy Cell Leukemia Market
- 7.3.4. Spain Hairy Cell Leukemia Market
- 7.3.5. Italy Hairy Cell Leukemia Market
- 7.3.6. Rest of Europe Hairy Cell Leukemia Market
7.4. Asia-Pacific Hairy Cell Leukemia Market Snapshot
- 7.4.1. China Hairy Cell Leukemia Market
- 7.4.2. India Hairy Cell Leukemia Market
- 7.4.3. Japan Hairy Cell Leukemia Market
- 7.4.4. Australia Hairy Cell Leukemia Market
- 7.4.5. South Korea Hairy Cell Leukemia Market
- 7.4.6. Rest of Asia Pacific Hairy Cell Leukemia Market
7.5. Latin America Hairy Cell Leukemia Market Snapshot
- 7.5.1. Brazil Hairy Cell Leukemia Market
- 7.5.2. Mexico Hairy Cell Leukemia Market
- 7.5.3. Rest of Latin America Hairy Cell Leukemia Market
7.6. Rest of The World Hairy Cell Leukemia Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Company Profiles
- 8.2.1. Amgen Inc.
  - 8.2.1.1. Key Information
  - 8.2.1.2. Overview
  - 8.2.1.3. Financial (Subject to Data Availability)
  - 8.2.1.4. Product Summary
  - 8.2.1.5. Recent Developments
- 8.2.2. AstraZeneca PLC
- 8.2.3. Gilead Sciences
- 8.2.4. F. Hoffmann-La Roche Ltd
- 8.2.5. Astellas Pharma
- 8.2.6. Johnson & Johnson
- 8.2.7. Merck KGaA
- 8.2.8. Biogenomics Limited
- 8.2.9. AbbVie Inc.
- 8.2.10. Pfizer Inc.

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

簡介目錄圖表

LIST OF TABLES

TABLE 1. Global Hairy Cell Leukemia Market, report scope
TABLE 2. Global Hairy Cell Leukemia Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Hairy Cell Leukemia Market estimates & forecasts by Therapy 2019-2029 (USD Billion)
TABLE 4. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Hairy Cell Leukemia Market
TABLE 69. List of primary sources, used in the study of global Hairy Cell Leukemia Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered